- Home
- ORGO vs NKX Comparison
ORGO vs NKX Comparison
Compare ORGO & NKX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- NKX
- Stock Information
- Founded
- ORGO 1985
- NKX 2002
- Country
- ORGO United States
- NKX United States
- Employees
- ORGO N/A
- NKX N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- NKX Finance/Investors Services
- Sector
- ORGO Health Care
- NKX Finance
- Exchange
- ORGO Nasdaq
- NKX Nasdaq
- Market Cap
- ORGO 620.3M
- NKX 562.3M
- IPO Year
- ORGO N/A
- NKX N/A
- Fundamental
- Price
- ORGO $4.92
- NKX $12.44
- Analyst Decision
- ORGO Buy
- NKX
- Analyst Count
- ORGO 2
- NKX 0
- Target Price
- ORGO $7.50
- NKX N/A
- AVG Volume (30 Days)
- ORGO 729.3K
- NKX 109.3K
- Earning Date
- ORGO 11-11-2025
- NKX 01-01-0001
- Dividend Yield
- ORGO N/A
- NKX 4.37%
- EPS Growth
- ORGO N/A
- NKX N/A
- EPS
- ORGO N/A
- NKX N/A
- Revenue
- ORGO $429,531,000.00
- NKX N/A
- Revenue This Year
- ORGO $2.57
- NKX N/A
- Revenue Next Year
- ORGO $9.80
- NKX N/A
- P/E Ratio
- ORGO N/A
- NKX N/A
- Revenue Growth
- ORGO N/A
- NKX N/A
- 52 Week Low
- ORGO $2.48
- NKX $9.78
- 52 Week High
- ORGO $6.71
- NKX $12.00
- Technical
- Relative Strength Index (RSI)
- ORGO 54.02
- NKX 76.85
- Support Level
- ORGO $4.75
- NKX $11.75
- Resistance Level
- ORGO $5.10
- NKX $11.87
- Average True Range (ATR)
- ORGO 0.21
- NKX 0.10
- MACD
- ORGO -0.01
- NKX 0.07
- Stochastic Oscillator
- ORGO 51.40
- NKX 83.73
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About NKX Nuveen California AMT-Free Quality Municipal Income Fund
Nuveen California AMT-Free Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objectives are to provide current income exempt from regular federal and California income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.